Anuh Pharma Faces Significant Selling Pressure with 29.97% Year-to-Date Loss and Declining Stock Price

Anuh Pharma Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, reflecting a challenging performance in the market. Over the past week, Anuh Pharma has declined by 4.10%, while the Sensex has gained 1.01%. The disparity is even more pronounced over the past month, with Anuh Pharma down 10.07% compared to the Sensex's modest increase of 0.75%. In the longer term, Anuh Pharma's performance has been underwhelming, with a 23.14% drop over the last three months and a staggering 29.97% decline year-to-date. The stock has consistently underperformed relative to the Sensex, which has risen by 6.22% in the same timeframe. The price summary indicates that Anuh Pharma is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further highlighting the stock's struggles. Potential contributing factors to this selling pressure may include broader market trends, sector-specific challenges, or company-specific issues, although specific details were not provided.